Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice - Wikidata - wikimedia - TriplyDB

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

http://www.wikidata.org/entity/Q36972748

about

The balance of powers: Redox regulation of fibrogenic pathways in kidney injury Similarity in Transcytosis of nNOSα in Enteric Nerve Terminals and Beta Cells of Pancreatic Islet New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.Diabetes regulates mitochondrial biogenesis and fission in mouse neurons.The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice.Mechanisms of disease: the oxidative stress theory of diabetic neuropathy Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.Effect of pioglitazone on nerve conduction velocity of the median nerve in the carpal tunnel in type 2 diabetes patients.Inflammation as a Therapeutic Target for Diabetic Neuropathies.Mouse models of diabetic neuropathy.Hyperlipidemia: a new therapeutic target for diabetic neuropathy.Diabetic neuropathy: cellular mechanisms as therapeutic targets.Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis.Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats.

P2860

Q26786137-49FCDB10-6F24-4618-9514-0AF672CF2952 Q28085023-1C90D33C-39FF-41D3-A37A-1B9475173939 Q30235132-180AAA58-A2EA-4A26-A56D-D183E3A23BC9 Q33571558-035578F5-4ED9-4FFC-8990-B04DB8AA82C2 Q34135732-8C7D3E87-9A8E-4AA9-8C10-08FE97E430D7 Q34553052-162AC227-5E50-42A7-8E8A-5FF1F86E6B48 Q35173711-99DBF4FE-23CE-40D3-BF28-A5375DF7C534 Q35579658-7B3B3F03-FD4F-4789-99E4-D8440E8E4238 Q36293649-ED68C52C-09DC-467C-AB4C-1D7028C6D878 Q36477207-8D9A7CF8-4D79-472D-BB0E-9462E6B5F162 Q36535440-5EB1B055-24FA-44AD-A73E-756CBA35A883 Q36879268-7DB83165-4428-4E87-8FF6-D7A8F48FF60E Q36889267-72674AF4-2DD6-4C00-9BC3-9E1F23576FAA Q37168753-EB044443-92E2-48E8-A9A8-22DADD195E8E Q37193699-82ACCB17-20E0-4BCD-9DFA-820B7D7CA046 Q37360464-34A7019A-C6D2-4519-9EE5-879B64FDBFE3 Q37411532-F9E85CE6-8E3E-4BF4-A2C9-33ADD41C8941 Q37450547-2EE4463C-A7A1-465B-86E0-840B47EBAF51 Q37655239-8EE73998-EE00-41C8-9EC0-5D5B6DB9CCFF Q37659233-B5C3BCEB-162D-4D0E-A68C-E37D272085D9 Q37930962-3AE42519-0BD4-450A-8B5F-B3CAD918EBD3 Q38319146-374DE9D7-E6DB-4FFA-9FE5-19E1EBD5470F Q47380940-9360792D-F22B-4DAF-B207-18AFCB8DEB11 Q52650664-02D3EF0E-5A19-4299-AC27-26EA5A2D563B Q53295371-584C73C4-C56F-4ACE-821A-6E0E26FAFDDD

P2860

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

http://www.wikidata.org/entity/Q36972748

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

@en

type

label

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

@en

prefLabel

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

@en

P1433

Q36972748-51711AF6-B43D-49C8-A76B-E4AD778C976C

P1476

Q36972748-41193BC0-6BEE-49FF-8772-04335FC150E6

P2093

Q36972748-28398548-A55E-4C79-96B1-268515386296

Q36972748-2B7A61E2-ED10-4435-8B9B-7C4A3E52ADB5

Q36972748-5AA2891E-926E-4023-A1C0-82981AD5DB91

Q36972748-AEBAA039-9D71-4A1F-9E91-6DFB54DF7FFE

Q36972748-CBE4DDF3-13BC-4029-93B7-13E736431A28

Q36972748-CFCD2C57-138B-4558-8BEB-EB4AC1E5E8A7

P2860

Q36972748-02FA70FA-74EC-4137-9B4B-D103AF80086C

Q36972748-1584C6B2-8B0A-4533-A456-F48D083FD0D8

Q36972748-1B3FA344-325C-44A9-B758-2A371F06CA51

Q36972748-2A0DC7D6-33A7-480D-A9C6-B653E942E155

Q36972748-33EE8014-FCF2-44AB-B4A8-73E1E5E63C14

Q36972748-3E8DDA80-6162-497F-9E9C-12976D55773C

Q36972748-3FC4AB84-6F2C-4C18-8F7E-94ADBFFD6F35

Q36972748-4FE46A97-7AF8-42E8-8936-FD5566BD36E2

Q36972748-55A3A601-97E7-4A68-AD94-B9B86B4D9C15

Q36972748-5F5EB048-4B8A-4F82-998E-F4CC0EC9B1B3

P304

Q36972748-8854A57D-1F19-4A96-97DA-F83FF60B88AC

P31

Q36972748-97BDF779-DAF9-4EA3-A6B0-5D58F68F2DB9

P356

Q36972748-78A6CB72-327C-419F-97BE-2C8AE77FDEF2

P407

Q36972748-D709F078-174B-451B-AF69-5F057FE6FD37

P433

Q36972748-D414E8C1-4AA1-4879-B112-310FA302C4FC

P478

Q36972748-CA01BF20-B1B0-4FC0-A26E-8966A881DCBE

P577

Q36972748-40504E08-01BA-472A-8E90-676D78755657

P5875

Q36972748-1AA4E845-AF31-4811-90E8-13C5D680717C

P698

Q36972748-1EE43574-F66C-41C0-A7BC-15766438573D

P932

Q36972748-83DE2388-ACAF-407B-8903-C632865189A6

P356

P1433

P1476

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

@en

P2093

Eva L Feldman

http://www.w3.org/2001/XMLSchema#string

Frank C Brosius

http://www.w3.org/2001/XMLSchema#string

Kelli A Sullivan

http://www.w3.org/2001/XMLSchema#string

Matthias Kretzler

http://www.w3.org/2001/XMLSchema#string

Subramaniam Pennathur

http://www.w3.org/2001/XMLSchema#string

Timothy D Wiggin

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data.

Sp1- and Krüppel-like transcription factors

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

Peroxisome proliferator-activated receptors: nuclear control of metabolism

Hic-5 regulates an epithelial program mediated by PPARgamma

A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes

The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.

Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study.

P304

4928-4937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2008-0869

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5271545

http://www.w3.org/2001/XMLSchema#string

P698

18583417

http://www.w3.org/2001/XMLSchema#string

P932

2582925

http://www.w3.org/2001/XMLSchema#string